Templeman Blaine 4
4 · ADURO BIOTECH, INC. · Filed Sep 20, 2017
Insider Transaction Report
Form 4
Templeman Blaine
Executive VP, General Counsel
Transactions
- Sale
Common Stock
2017-09-18$11.20/sh−2,884$32,301→ 58,834 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016.